Diagnostics News and analysis on diagnostic technologies and applications. Bionano Genomics Outlines Studies Comparing Optical Genome Mapping With Clinical Standard Premium The San Diego-based firm also said it expects European customers to get optical genome mapping-based assays for leukemia and FSHD accredited. DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand The company said that its Q1 revenue growth was driven in part by SARS-CoV-2 test revenues of €102.0 million, booked mainly in the US, Canada, and Europe. DermTech Q1 Revenues up 62 Percent The firm processed approximately 9,400 billable samples in Q1, a 62 percent increase compared to approximately 5,800 samples in Q1 of 2020. Co-Diagnostics Posts Q1 Revenue Boost on SARS-CoV-2 Test Sales The company posted a first quarter net profit of $7.9 million, or $.26 per share, compared with a year-ago net loss of $1.1 million, or $.05 per share. Lucira Health Posts $4.5M in Sales in First Quarter as Publicly Traded Firm The firm had a net loss of $13.3 million, or $.58 per share, in Q1 2021 compared to a net loss of $1.7 million, or $.76 per share, a year ago. May 13, 2021 Progenity Q1 Revenues up 46 Percent May 13, 2021 Viome Forays Outside Molecularly Informed DTC Wellness Testing With Oral Cancer Assay Premium May 13, 2021 Diacarta Positioning Liquid Biopsy Assay to Gauge Chemotherapy Response in Multiple Cancers Premium May 13, 2021 Interline Therapeutics Taking Protein Interaction-Based Approach to Drug Development Premium May 13, 2021 Becton Dickinson Gets CE Mark for At-Home Self-Collected HPV Test Indication May 13, 2021 OpGen Q1 Revenues Rise 34 Percent on Combination With Curetis May 13, 2021 LGC SeraCare Joins Diaceutics DXRX Network for Precision Medicine Diagnostics May 13, 2021 Cue Health Raises $235M in Private Funding May 13, 2021 Fujifilm, Helio Health Collaborate on Blood-Based Liver Cancer Test May 13, 2021 Genetron Health, Siemens Healthineers Partner to Promote Lung Cancer Molecular Testing in China May 12, 2021 Biocept Q1 Revenues Up Dramatically as COVID-19 Testing Boost Lingers May 12, 2021 PerkinElmer Acquiring Nexcelom Bioscience for $260M May 12, 2021 Talis Biomedical Discusses Point-of-Care Thesis in First Earnings Call as a Public Company Premium May 12, 2021 Bluestar Genomics Raises $70M in Series C Funding Round May 12, 2021 Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms Premium May 12, 2021 Talis Biomedical Q1 Revenues Spike on Grant Funding May 12, 2021 Prenatal Testing Startup Juno Diagnostics Closes $25M Series A Financing Round May 12, 2021 Interpace Biosciences Q1 Revenues Up 8 Percent May 11, 2021 Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer May 11, 2021 Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development Load More Breaking News New California Condor Genome Assembly Reveals High Genetic Diversity DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand New Products Posted to GenomeWeb: Bio-Rad, GP-write, Twist Bioscience, KogeneBiotech, More In Brief This Week: Pacific Biosciences, PerkinElmer, Unilabs, and More People in the News: New Appointments at Berkeley Lights, Castle Bio, IsoPlexis, More DermTech Q1 Revenues up 62 Percent The Scan Call to Look Again More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration. Not Always Trusted In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports. Identified Decades Later A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports. Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.